Back To Schedule
Wednesday, January 22 • 4:25pm - 5:00pm
Track B: Dive Into Risk-Based Monitoring (RBM) As A Business Intelligence Of The Clinical Trials. Are We Realizing The Full Potential?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Elevate monitoring to the next level through continuous improvement, organizational silos, reduction, and increased efficiency
  • Understand key risk indicators, thresholds, algorithms, and issue management
  • Envision RBM as a business intelligence function in the clinical trials oversight to expand its benefits

avatar for Vera Pomerantseva

Vera Pomerantseva

Senior Central Monitoring Lead, Bristol-Myers Squibb
Over 18 years of pharmaceutical industry experience in various functions, such as analytics, clinical operations, project management, trainings and risk-based monitoring. Published author of multiple articles in international magazines, such as Pharmaceutical Medicine Journal of New... Read More →

Wednesday January 22, 2020 4:25pm - 5:00pm EST